Skip to content

A Prospective Observational Case Series of a Four-ring-haptic Acrylic One-piece IOL

Observational Case Series of the Implantation of Intraocular Lens QUATRIX® Aspheric Evolutive Pre-loaded.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01244373
Acronym
Qu01
Enrollment
9
Registered
2010-11-19
Start date
2008-05-31
Completion date
2009-08-31
Last updated
2010-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Best-corrected visual acuity, posterior capsule opacification, QUATRIX® Aspheric Evolutive pre-loaded

Brief summary

To describe biocompatibility, postoperative results and complications after implantation of the Corneal Quatrix Evolutive (Corneal, Croma, Austria) intraocular lens, a hydrophilic acrylic intraocular lens (IOL) with 4-haptic design and 360° sharp optic edge.

Detailed description

In this prospective case series the Corneal Quatrix Evolutive IOL was implanted in 14 eyes of nine patients with senile cortico-nuclear cataract. A standardized surgical technique and post-operative regimen were applied. Six months postoperatively best corrected visual acuity (BCVA), refraction and complications (especially) posterior capsule opacification (PCO) were analysed.

Interventions

None listed

Sponsors

Department of ophthalmology, General Hospital Linz
CollaboratorUNKNOWN
General Hospital Linz
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Patients with senile cortico-nuclear cataracts without previous intraocular surgery

Exclusion criteria

* Dilated pupil size of \< 6 mm * long-term anti-inflammatory treatment * previous history of intraocular surgery * previous history of corneal endothelial damage * previous history of ocular trauma * traumatic cataract * history of uveitis * diabetic retinopathy * advanced macular degeneration

Design outcomes

Primary

MeasureTime frameDescription
Best-corrected visual acuity (BCVA)Six monthsThe best-corrected visual acuity is assessed with glasses after cataract operation

Secondary

MeasureTime frameDescription
Posterior capsule opacificationSix monthsThe posterior capsule opacification is assessed by slit lamp examination and subjective grading

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026